Telaglenastat hydrochloride
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Telaglenastat hydrochloride, covering 2025-06-19 to 2025-07-01. Get the full timeline:
Most recent: Clinical Trial Update: Testing Whether Cancers With Specific Mutations Respond Better to Glutaminase Inhibitor, Telaglenastat Hydrochloride, Anti-Cancer Treatment, BeGIN Study [Phase 2]